戻る Agenda
Global Clinical Trials: Make Them Really Global and Involve Africa
Session Chair(s)
Adama Ibrahim, MBA
Vice President, Digital Strategy and Change Management
Novo Nordisk, United Kingdom
Changing how we do global clinical trials, with the inclusion of emerging markets in this development process, is imperative. A panel of experts will discuss how to plan and involve pharma/biotech and technology providers.
Learning Objective : Describe ways in which to integrate emerging markets in global clinical trials using innovative technologies;Discuss approaches to process optimization, mobile health digitalization, blockchain, and change management on how to undertake clinical trials within Africa as the process model: Identify challenges and solutions from actual cases and experience.
Speaker(s)
Next Generation Real World Evidence with Blockchain
Alexis Normand, MPA, MSC
Embleema, United States
Head of Blockchain for Health Consortium
Panelist
Tina Barton, BSN, MD, PMP
Emerging Markets Quality Trials (EMQT) , United Kingdom
Chief Operating Officer